These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1197242)

  • 1. Removal by dialysis of methylguanidine from body fluids.
    Barsotti G; Giovannetti S
    Proc Eur Dial Transplant Assoc; 1975; 11():105-11. PubMed ID: 1197242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dialysis of methylguanidine and hypothesis on the middle molecules].
    Barsotti G; Giovannetti S
    Ateneo Parmense Acta Biomed; 1975; 46(5):317-30. PubMed ID: 1232993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis.
    Eloot S; van Biesen W; Dhondt A; de Smet R; Marescau B; De Deyn PP; Verdonck P; Vanholder R
    Nephrol Dial Transplant; 2009 Jul; 24(7):2225-32. PubMed ID: 19225018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Kt/V and creatinine clearance with outcomes in anuric peritoneal dialysis patients.
    Fried L; Hebah N; Finkelstein F; Piraino B
    Am J Kidney Dis; 2008 Dec; 52(6):1122-30. PubMed ID: 18617306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis of methylguanidine.
    Giovannetti S; Barsotti G
    Kidney Int; 1974 Sep; 6(3):177-83. PubMed ID: 4425483
    [No Abstract]   [Full Text] [Related]  

  • 6. Residual renal function and post dialysis urea rebound.
    Carofei O; Taratufolo A; Atti S; Fringuello F; Alaimo M
    EDTNA ERCA J; 1999; 25(2):7-8. PubMed ID: 10531872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H; Fürst P; Oulés R; Yahiel V; Zimmerman L; Bergström J
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre.
    Chung SH; Heimbürger O; Lindholm B; Lee HB
    Nephrol Dial Transplant; 2005 Jun; 20(6):1207-13. PubMed ID: 15784640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cystatin C: a surrogate marker for the characteristics of peritoneal membrane in dialysis patients.
    Al-Wakeel JS; Hammad D; Memon NA; Tarif N; Shah I; Chaudhary A
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):227-31. PubMed ID: 19237809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
    Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
    Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity arising from guanidine compounds: role of methylguanidine as a uremic toxin.
    Barsotti G; Bevilacqua G; Morelli E; Cappelli P; Balestri PL; Giovannetti S
    Kidney Int Suppl; 1975 Feb; (3):299-301. PubMed ID: 1057702
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of recombinant human erythropoietin on synthesis of methylguanidine in uraemic patients on haemodialysis or continuous ambulatory peritoneal dialysis.
    Sasagawa I; Nakada T; Kubota Y; Sawamura T; Suzuki H; Hashimoto T
    Int Urol Nephrol; 1994; 26(6):701-5. PubMed ID: 7759207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hemodialysis on serum guanidine and methylguanidine levels.
    Perez G; Santos B
    Proc Clin Dial Transplant Forum; 1973; 3():110-3. PubMed ID: 4806625
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uraemic toxins.
    Dawborn JK
    Aust N Z J Med; 1981; 11(Suppl 1):40-5. PubMed ID: 6942801
    [No Abstract]   [Full Text] [Related]  

  • 17. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
    Leypoldt JK; Burkart JM
    Adv Perit Dial; 2002; 18():26-31. PubMed ID: 12402582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrative description of dialysis adequacy indices for different treatment modalities and schedules of dialysis.
    Debowska M; Waniewski J; Lindholm B
    Artif Organs; 2007 Jan; 31(1):61-9. PubMed ID: 17209962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.